Increased expression of carbonic anhydrase IX in oral submucous fibrosis and oral squamous cell carcinoma

Clinical Chemistry and Laboratory Medicine

Volumn 52, Issue 9, 2014, Pages 1367-1377

  Yang, Jia Sin ^a   Chen, Mu Kuan ^a,b   Yang, Shun Fa ^a   Chang, Yu Chao ^a,c   Su, Shih Chi ^d   Chiou, Hui Ling ^a   Chien, Ming Hsien ^a,e,f   Lin, Chiao Wen ^a,c  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^f TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Carbonic anhydrase IX (CAIX); Chewed areca nuts; Oral cancer; Oral submucous fibrosis

Indexed keywords

ARECOLINE; CARBONATE DEHYDRATASE IX; CA9 PROTEIN, HUMAN; CARBONATE DEHYDRATASE; MESSENGER RNA; TUMOR ANTIGEN;

ADULT; ARTICLE; BETEL NUT; CANCER GROWTH; CANCER PATIENT; CHEEK MUCOSA; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE SEVERITY; ENZYME INDUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MOUTH DISEASE; MOUTH SQUAMOUS CELL CARCINOMA; NON INVASIVE PROCEDURE; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; ADVERSE EFFECTS; AGED; ARECA; BLOOD; CARCINOMA, SQUAMOUS CELL; CASE CONTROL STUDY; CELL CULTURE; DRUG EFFECTS; ENZYMOLOGY; GENETICS; METABOLISM; MIDDLE AGED; MOUTH MUCOSA; MOUTH NEOPLASMS; ORAL SUBMUCOUS FIBROSIS; PROGNOSIS; UPREGULATION;

ARECA; ARECA CATECHU;

ADULT; AGED; ANTIGENS, NEOPLASM; ARECA; ARECOLINE; CARBONIC ANHYDRASES; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CELLS, CULTURED; FEMALE; FIBROBLASTS; HUMANS; MALE; MIDDLE AGED; MOUTH MUCOSA; MOUTH NEOPLASMS; ORAL SUBMUCOUS FIBROSIS; PROGNOSIS; RNA, MESSENGER; UP-REGULATION;

EID: 84911417799     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2014-0129     Document Type: Article

References (39)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61:69-90.
2. Krishna Rao SV, Mejia G, Roberts-Thomson K, Logan R. Epidemiology of oral cancer in Asia in the past decade - an update (2000-2012). Asian Pac J Cancer Prev 2013;14:5567-77.
3. Chien MH, Lin CW, Cheng CW, Wen YC, Yang SF. Matrix metallo-proteinase-2 as a target for head and neck cancer therapy. Expert Opin Ther Targets 2013;17:203-16.
4. Peacock S, Pogrel A, Schmidt BL. Exploring the reasons for delay in treatment of oral cancer. Am Dent Assoc 2008;139:1346-52.
5. Supuran CT. Carbonic anhydrases - an overview. Curr Pharm Des 2008;14:603-14.
6. Swietach P, Hulikova A, Vaughan-Jones RD, Harris AL. New insights into the physiological role of carbonic anhydrase IX in tumour pH regulation. Oncogene 2010;29:6509-21.
7. Liu CM, Lin YM, Yeh KT, Chen MK, Chang JH, Chen CJ, et al. Expression of carbonic anhydrases I/II and the correlation to clinical aspects of oral squamous cell carcinoma analyzed using tissue microarray. J Oral Pathol Med 2012;41:533-9.
8. Zatovicova M, Jelenska L, Hulikova A, Csaderova L, Ditte Z, Ditte P, et al. Carbonic anhydrase IX as an anticancer therapy target: preclinical evaluation of internalizing monoclonal antibody directed to catalytic domain. Curr Pharm Des 2010;16:3255-63.
9. Müller V, Riethdorf S, Rack B, Janni W, Fasching PA, Solomayer E, et al. Prospective evaluation of serum tissue inhibitor of metalloproteinase 1 and carbonic anhydrase IX in correlation to circulating tumor cells in patients with metastatic breast cancer. Breast Cancer Res 2011;13:R71.
10. Ilie M, Mazure NM, Hofman V, Ammadi RE, Ortholan C, Bonnetaud C, et al. High levels of carbonic anhydrase IX in tumour tissue and plasma are biomarkers of poor prognostic in patients with non-small cell lung cancer. Br J Cancer 2010;102:1627-35.
11. Woelber L, Mueller V, Eulenburg C, Schwarz J, Carney W, Jaenicke F, et al. Serum carbonic anhydrase IX during first-line therapy of ovarian cancer. Gynecol Oncol 2010;117:183-8.
12. Tostain J, Li G, Gentil-Perret A, Gigante M. Carbonic anhydrase 9 in clear cell renal cell carcinoma: a marker for diagnosis, prognosis and treatment. Eur J Cancer 2010;46:3141-8.
13. Choschzick M, Oosterwijk E, Müller V, Woelber L, Simon R, Moch H, et al. Overexpression of carbonic anhydrase IX (CAIX) is an independent unfavorable prognostic marker in endometrioid ovarian cancer. Virchows Arch 2011;459:193-200.
14. Pastorekova S, Zatovicova M, Pastorek J. Cancer-associated carbonic anhydrases and their inhibition. Curr Pharm Des 2008;14:685-98.
15. Kondo Y, Yoshikawa K, Omura Y, Shinohara A, Kazaoka Y, Sano J, et al. Clinicopathological significance of carbonic anhydrase 9, glucose transporter-1, Ki-67 and p53 expression in oral squamous cell carcinoma. Oncol Rep 2011;25:1227-33.
16. Beasley NJ, Wykoff CC, Watson PH, Leek R, Turley H, Gatter K, et al. Carbonic anhydrase IX, an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis, and microvessel density. Cancer Res 2001;61:5262-7.
17. Brockton N, Dort J, Lau H, Hao D, Brar S, Klimowicz A, et al. High stromal carbonic anhydrase IX expression is associated with decreased survival in P16-negative head-and-neck tumors. Int J Radiat Oncol Biol Phys 2011;80:249-57.
18. Kim SJ, Shin HJ, Jung KY, Baek SK, Shin BK, Choi J, et al. Prognostic value of carbonic anhydrase IX and Ki-67 expression in squamous cell carcinoma of the tongue. Jpn J Clin Oncol 2007;37:812-9.
19. Peridis S, Pilgrim G, Athanasopoulos I, Parpounas K. Carbonic anhydrase-9 expression in head and neck cancer: a meta-analysis. Eur Arch Otorhinolaryngol 2011;268:661-70.
20. Zhou GX, Ireland J, Rayman P, Finke J, Zhou M. Quantification of carbonic anhydrase IX expression in serum and tissue of renal cell carcinoma patients using enzyme-linked immunosorbent assay: prognostic and diagnostic potentials. Urology 2010;75:257-61.
21. Lian IB, Tseng YT, Su CC, Tsai KY. Progression of precancerous lesions to oral cancer: results based on the Taiwan National Health Insurance Database. Oral Oncol 2013;49:427-30.
22. Yang SF, Tsai CH, Chang YC. The upregulation of heat shock protein 47 expression in human buccal fibroblasts stimulated with arecoline. J Oral Pathol Med 2008;37:206-10.
23. Yang SF, Hsieh YS, Tsai CH, Chen YJ, Chang YC. Increased plasminogen activator inhibitor-1/tissue type plasminogen activator ratio in oral submucous fibrosis. Oral Dis 2007;13:234-8.
24. Yang SF, Hsieh YS, Tsai CH, Chou MY, Chang YC. The upregulation of type I plasminogen activator inhibitor in oral submucous fibrosis. Oral Oncol 2003;39:367-72.
25. Chung TT, Pan MS, Kuo CL, Wong RH, Lin CW, Chen MK, et al. Impact of RECK gene polymorphisms and environmental factors on oral cancer susceptibility and clinicopathologic characteristics in Taiwan. Carcinogenesis 2011;32:1063-8.
26. Chien MH, Yang JS, Chu YH, Lin CH, Wei LH, Yang SF, et al. Impacts of CA9 gene polymorphisms and environmental factors on oral-cancer susceptibility and clinicopathologic characteristics in Taiwan. PLoS One 2012;7:e51051.
27. th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 2010;17:1471-4.
28. Wind TC, Messenger MP, Thompson D, Selby PJ, Banks RE. Measuring carbonic anhydrase IX as a hypoxia biomarker: differences in concentrations in serum and plasma using a commercial enzyme-linked immunosorbent assay due to influences of metal ions. Ann Clin Biochem 2011;48:112-20.
29. Teng YH, Tsai HT, Hsieh YS, Chen YC, Lin CW, Lee MC, et al. Elevated erythrocyte carbonic anhydrase activity is a novel clinical marker in hyperventilation syndrome. Clin Chem Lab Med 2009;47:441-5.
30. Pérez-Sayáns M, Suárez-Peñaranda JM, Pilar GD, Supuran CT, Pastorekova S, Barros-Angueira F, et al. Expression of CA-IX is associated with advanced stage tumors and poor survival in oral squamous cell carcinoma patients. J Oral Pathol Med 2012;41:667-74.
31. Brockton NT, Klimowicz AC, Bose P, Petrillo SK, Konno M, Rudmik L, et al. High stromal carbonic anhydrase IX expression is associated with nodal metastasis and decreased survival in patients with surgically-treated oral cavity squamous cell carcinoma. Oral Oncol 2012;48:615-22.
32. Choi SW, Kim JY, Park JY, Cha IH, Kim J, Lee S. Expression of carbonic anhydrase IX is associated with postoperative recurrence and poor prognosis in surgically treated oral squamous cell carcinoma. Hum Pathol 2008;39:1317-22.
33. Lin CW, Tseng SW, Yang SF, Ko CP, Lin CH, Wei LH, et al. Role of lipocalin 2 and its complex with matrix metalloproteinase-9 in oral cancer. Oral Dis 2012;18:734-40.
34. Li YZ, Li SL, Li X, Wang LJ, Wang JL, Xu JW, et al. Expression of endogenous hypoxia markers in vulvar squamous cell carcinoma. Asian Pac J Cancer Prev 2012;13:3675-80.
35. Tanaka N, Kato H, Inose T, Kimura H, Faried A, Sohda M, et al. Expression of carbonic anhydrase 9, a potential intrinsic marker of hypoxia, is associated with poor prognosis in oesophageal squamous cell carcinoma. Br J Cancer 2008;99:1468-75.
36. Zhu Y, Zhou XY, Yao XD, Zhang SL, Dai B, Zhang HL, et al. Prognostic value of carbonic anhydrase IX expression in penile squamous cell carcinoma: a pilot study. Urol Oncol 2013;31:706-11.
37. Kim SJ, Rabbani ZN, Vollmer RT, Schreiber EG, Oosterwijk E, Dewhirst MW, et al. Carbonic anhydrase IX in early-stage non-small cell lung cancer. Clin Cancer Res 2004;10:7925-33.
38. Lambert R, Sauvaget C, de Camargo Cancela M, Sankaranarayanan R. Epidemiology of cancer from the oral cavity and oropharynx. Eur J Gastroenterol Hepatol 2011;23:633-41.
39. Lee SS, Tsai CH, Yang SF, Ho YC, Chang YC. Hypoxia inducible factor-1α expression in areca quid chewing-associated oral squamous cell carcinomas. Oral Dis 2010;16:696-701.